CEO Statement on Chadwick Boseman’s Death
From Michael Sapienza, CEO of the Colorectal Cancer Alliance:
"The Colorectal Cancer Alliance mourns with Chadwick Boseman’s fans, friends, and family over the loss of this bright star to colon cancer. Somberly, we share that young-onset colorectal cancer is on the rise and cuts short thousands of lives every year.
Colorectal cancer awareness is hampered by an intense stigma, particularly in the Black community. Cancer is a personal battle, and we respect Boseman’s choice to shield the public from his diagnosis. The Alliance, however, encourages open conversations about this disease. Even superheroes can develop colorectal cancer.
Colorectal cancer is the second deadliest cancer in the U.S. when men and women are combined, and it disproportionately affects our black and brown communities. With education and awareness to defeat the stigma, resources for those diagnosed, and innovative research toward cures, we can end colorectal cancer in our lifetime.
Learn more information on health equity and colorectal cancer.
Donate to the Alliance's lifesaving programs.
Media inquiries:
Maurisa Turner-Potts at maurisapotts@gmail.com or (703) 501-6289
Top resources
Alliance Honors Survivors, Encourages Screening and Advocates for Research During National Cancer Survivors Month
In recognition of National Cancer Survivors Month this June, the Colorectal Cancer Alliance (Alliance) is shining a light on the more than 1.5 million colorectal cancer survivors in the United States, celebrating their strength while calling attention to increasing rates of colorectal cancer and the urgent need for more screening and research to end the disease.
Alliance Announces New Leadership Roles
The additions to the Colorectal Cancer Alliance's all bring deep expertise and a shared passion for the mission to end colorectal cancer in our lifetime.
Alliance Launches “Screen Smart” To Make Lifesaving Cancer Screenings Easier for Everyone
The Screen Smart initiative brings together insights from medical experts, researchers, and advocates to make colorectal cancer screening decisions easier for both patients and healthcare providers.